The broad agenda - PPMD notes the detailed agenda will be provided later.
One reference to gene therapy here - more on inflammation, dystrophin and cardiac management that's part of our bag ....
Wednesday,
July 226:00 PM - 8:00 PM EDT
- Welcome Address
- COVID-19 and Re-Entry: Where Are We Now?
- In the Pipeline: Reducing Inflammation clinical trial discussions
Thursday,
July 231:00 PM EDT
Lunch ‘n Learn
6:00-8:00 PM EDT
- Building Resilience: Overcoming Compassion Fatigue and Burnout
- In the Pipeline: Restoring Dystrophin clinical trial discussions
Friday,
July 241:00 PM EDT
Lunch ‘n Learn
3:00-6:25 PM EDT
- In the Pipeline: Downstream Targets clinical trial discussions
- Duchenne Care: Endocrinology in Duchenne: Bone Health, Growth and Puberty
- Duchenne Care: Acute Pulmonary Management
7:00 - 8: 30 PM EDT
- In the Pipeline: Gene Therapy clinical trial discussions
8:45 PM EDT
Social Hangout events for Moms, Dads, Grandparents and of course teens and young adults.Saturday,
July 259:00 AM EDT
Yoga
10:30 AM -12:10 PM EDT
- Duchenne Care: Caring for Female Carriers of Duchenne
12:10-1:00 PM EDT
Lunch
1:00-2:00 PM EDT
Keynote Speaker
2:00-6:15 PM EDT
- In the Pipeline: Combating Fibrosis and Inflammation clinical trial discussions
- Duchenne Care: The Role of Physical Medicine & Rehabilitation (PM&R) in Neuromuscular Care
- Rescuing the Heart: Why Cardiac Intervention Is So Critical
- Future and Emerging Strategies in Duchenne
- Forums
- ASX - By Stock
- PER
- Video Interview with Mark Diamond
Video Interview with Mark Diamond, page-21
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $85.01M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.2¢ | $103.7K | 1.237M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 280000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 204084 | 0.082 |
3 | 287000 | 0.081 |
8 | 672686 | 0.080 |
6 | 413817 | 0.079 |
6 | 689399 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 280000 | 3 |
0.086 | 96543 | 1 |
0.088 | 27962 | 1 |
0.089 | 200000 | 1 |
0.090 | 604764 | 4 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online